x

Pesquisar um projeto de investigação

* (*) campo(s) de preenchimento obrigatório

27 Resultado(s)

Ordenados por

Financiado por um membro do IRDiRC =

Projetos de investigação

ALEMANHA

Bayern
GAUTING

AUSTRIA

WIEN
WIEN

Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis - AT
Allgemeines Krankenhaus der Stadt Wien
Universitätsklinik für Chirurgie

ESPANHA

Baleares
PALMA DE MALLORCA

Financiado por um membro do IRDiRCRole of MSCs in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and analysis of their reparative / antiinflammatory capacity in an experimental model of pulmonary fibrosis
IdISBa - Fundació Institut d'Investigació Sanitaria Illes Balears
Grupo de investigación en Inflamación, reparación y cáncer en enfermedades respiratorias

ESPANHA

Cataluña
SABADELL

Financiado por um membro do IRDiRCThe pulmonary microbiome in idiopathic pulmonary fibrosis
Institut d'Investigació i Innovació Parc Taulí
Área de Inflamación, inmunología y metabolismo

ESPANHA

Madrid
MADRID

Study of telomere length in IPF patients as a tool to know the genetic bases and counseling advise in the disease
Instituto de Investigaciones Biomédicas "Alberto Sols" (CSIC-UAM)
Laboratorio de enfermedades teloméricas (Laboratorio de Rosario Perona Abellón)

FINLANDIA

Finland
HELSINKI

Financiado por um membro do IRDiRCIdiopathic pulmonary fibrosis (IPF) -Development of therapeutic applications
University of Helsinki
Institute of Clinical Medicine

FRANCA

BOURGOGNE-FRANCHE-COMTE
DIJON

Financiado por um membro do IRDiRCSHOT-IPF: Small HSPs Inhibitors to Treat Idiopathic Pulmonary Fibrosis - FR
CHU Dijon Bourgogne - Hôpital François Mitterrand
Service de Pneumologie - Soins Intensifs, Appareillage Respiratoire

FRANCA

CENTRE-VAL DE LOIRE
TOURS

Financiado por um membro do IRDiRCAcoustic Waves and Helium/oxygen for Aerosol Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Faculté de Médecine, Université de Tours François Rabelais
Équipe Inserm 3 : « Aérosolthérapie et biothérapies à visée respiratoire »

FRANCA

ILE-DE-FRANCE
PARIS

Financiado por um membro do IRDiRCProtease-activated Receptor-2 and its agonist serine proteases in idiopathic pulmonary fibrosis
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et épidémiologie des maladies respiratoires (Inserm UMR 1152)

FRANCA

ILE-DE-FRANCE
PARIS

Financiado por um membro do IRDiRCFibroPRX : PRRX (Paired Related Homeobox Protein)-1 as a novel and key transcription factor in lung fibrosis: in search for innovative targets
Faculté de Médecine Paris Diderot Paris 7 - site Bichat
Physiopathologie et épidémiologie des maladies respiratoires (Inserm UMR 1152)

IRLANDA

County Dublin
DUBLIN

ITALIA

LOMBARDIA
MONZA

Nutritional Assessment in Idiopathic Pulmonary Fibrosis: a Pilot Study
Azienda Ospedaliera San Gerardo
Dipartimento Cardio-Toraco-Vascolare

PAISES BAIXOS

Utrecht
NIEUWEGEIN

Genetic predisposition to interstitital lung diseases and disease phenotypes
St. Antonius Ziekenhuis, locatie Nieuwegein
Longcentrum

JAPAO

JAPAN
ADDRESS : NOT PROVIDED - JP

Projetos de investigação multicêntricos